Bluesky Facebook Reddit Email

Scientists correct genetic illness thalassemia in human blood cells

Researchers used antisense oligonucleotides to block defective genes responsible for producing hemoglobin, restoring correct production of beta-globin and enabling cells to produce more hemoglobin. The correction could last for months and may be a simpler therapy than gene therapy.

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

A safer way of altering genes

Researchers at Chromos Molecular Systems have successfully passed an artificial chromosome to their offspring, paving the way for practical germline gene therapy. The technology could enable genetic changes to be inherited without disrupting other genes, offering a safer alternative to current methods.

Molecular Basis Of Leading Genetic Cause Of Infant Death Discovered

Researchers have discovered a novel function of the Survival Motor Neuron (SMN) protein essential for mRNA production in all cells. This finding links SMN deficiency to spinal muscular atrophy, a leading genetic cause of infant death, and paves the way for potential therapeutic interventions.

University Of Chicago Researcher Receives Packard Fellowship

Myuanan Long, a University of Chicago researcher, has received the David and Lucile Packard Fellowship to study gene evolution. He believes that new genes arise through shuffling and mixing of existing genes or gene fragments, with 'junk' DNA playing a crucial role in this process.

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Second Look Acquits Gene Of Role In Breast Cancer

Researchers at Johns Hopkins Medicine found that the TSG101 gene, previously identified as a tumor suppressor, was consistently normal and undamaged in human breast cancer cells. The cells exhibited abnormal RNA splicing, which may be a result of cancer cells trying to activate normal cell behaviors in an abnormal way.